Tislelizumab Injection Market: A Rising Star in Cancer Immunotherapy

agregó una foto Health

2026-09-15 07:30:08 - Translate -

The global tislelizumab injection market is experiencing remarkable growth, driven by the increasing incidence of cancer, advancements in immunotherapy, and the rising demand for effective treatment options. Tislelizumab, a humanized monoclonal antibody targeting PD-1, has emerged as a promising immune checkpoint inhibitor for the treatment of various cancers, including non-small cell lung...

0 Commentarios 0 Acciones 92 Views 0 Vista previa